Your browser doesn't support javascript.
loading
Comprehensive analysis of the mutation spectrum in 301 German ALS families.
Müller, Kathrin; Brenner, David; Weydt, Patrick; Meyer, Thomas; Grehl, Torsten; Petri, Susanne; Grosskreutz, Julian; Schuster, Joachim; Volk, Alexander E; Borck, Guntram; Kubisch, Christian; Klopstock, Thomas; Zeller, Daniel; Jablonka, Sibylle; Sendtner, Michael; Klebe, Stephan; Knehr, Antje; Günther, Kornelia; Weis, Joachim; Claeys, Kristl G; Schrank, Berthold; Sperfeld, Anne-Dorte; Hübers, Annemarie; Otto, Markus; Dorst, Johannes; Meitinger, Thomas; Strom, Tim M; Andersen, Peter M; Ludolph, Albert C; Weishaupt, Jochen H.
Afiliação
  • Müller K; Department of Neurology, Ulm University, Ulm, Germany.
  • Brenner D; Department of Neurology, Ulm University, Ulm, Germany.
  • Weydt P; Department of Neurology, Ulm University, Ulm, Germany.
  • Meyer T; Department of Neurodegenerative Diseases and Gerontopsychiatry, Bonn University, Bonn, Germany.
  • Grehl T; Department of Neurology, Charité Hospital, Humboldt University, Berlin, Germany.
  • Petri S; Department of Neurology, Alfried Krupp Hospital, Essen, Germany.
  • Grosskreutz J; Department of Neurology, Hannover Medical School, Hannover, Germany.
  • Schuster J; Department of Neurology, Jena University Hospital, Jena, Germany.
  • Volk AE; Department of Neurology, Ulm University, Ulm, Germany.
  • Borck G; Institute of Human Genetics, Ulm University, Ulm, Germany.
  • Kubisch C; Institute of Human Genetics, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Klopstock T; Institute of Human Genetics, Ulm University, Ulm, Germany.
  • Zeller D; Institute of Human Genetics, Ulm University, Ulm, Germany.
  • Jablonka S; Institute of Human Genetics, University Hospital Hamburg-Eppendorf, Hamburg, Germany.
  • Sendtner M; Department of Neurology, Friedrich-Baur-Institut, University of Munich, Munich, Germany.
  • Klebe S; German Center for Neurodegenerative Diseases (DZNE), Munich, Germany.
  • Knehr A; Department of Neurology, University of Würzburg, Würzburg, Germany.
  • Günther K; Institute of Clinical Neurobiology, University Hospital of Würzburg, Würzburg, Germany.
  • Weis J; Institute of Clinical Neurobiology, University Hospital of Würzburg, Würzburg, Germany.
  • Claeys KG; Department of Neurology, University of Würzburg, Würzburg, Germany.
  • Schrank B; Department of Neurology, University Duisburg-Essen, Essen, Germany.
  • Sperfeld AD; Department of Neurology, Ulm University, Ulm, Germany.
  • Hübers A; Department of Neurology, Ulm University, Ulm, Germany.
  • Otto M; Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
  • Dorst J; Institute of Neuropathology, RWTH Aachen University Hospital, Aachen, Germany.
  • Meitinger T; Department of Neurology, RWTH Aachen University Hospital, Aachen, Germany.
  • Strom TM; Department of Neurology, University Hospitals Leuven, Leuven, Belgium.
  • Andersen PM; Laboratory for Muscle Diseases and Neuropathies, Department of Neurosciences, Experimental Neurology, KU Leuven - University of Leuven, Leuven, Belgium.
  • Ludolph AC; Department of Neurology, DKD HELIOS Klinik Wiesbaden, Wiesbaden, Germany.
  • Weishaupt JH; Department of Neurology, Martin Luther University of Halle-Wittenberg, Halle/Saale, Germany.
J Neurol Neurosurg Psychiatry ; 89(8): 817-827, 2018 08.
Article em En | MEDLINE | ID: mdl-29650794
OBJECTIVES: Recent advances in amyotrophic lateral sclerosis (ALS) genetics have revealed that mutations in any of more than 25 genes can cause ALS, mostly as an autosomal-dominant Mendelian trait. Detailed knowledge about the genetic architecture of ALS in a specific population will be important for genetic counselling but also for genotype-specific therapeutic interventions. METHODS: Here we combined fragment length analysis, repeat-primed PCR, Southern blotting, Sanger sequencing and whole exome sequencing to obtain a comprehensive profile of genetic variants in ALS disease genes in 301 German pedigrees with familial ALS. We report C9orf72 mutations as well as variants in consensus splice sites and non-synonymous variants in protein-coding regions of ALS genes. We furthermore estimate their pathogenicity by taking into account type and frequency of the respective variant as well as segregation within the families. RESULTS: 49% of our German ALS families carried a likely pathogenic variant in at least one of the earlier identified ALS genes. In 45% of the ALS families, likely pathogenic variants were detected in C9orf72, SOD1, FUS, TARDBP or TBK1, whereas the relative contribution of the other ALS genes in this familial ALS cohort was 4%. We identified several previously unreported rare variants and demonstrated the absence of likely pathogenic variants in some of the recently described ALS disease genes. CONCLUSIONS: We here present a comprehensive genetic characterisation of German familial ALS. The present findings are of importance for genetic counselling in clinical practice, for molecular research and for the design of diagnostic gene panels or genotype-specific therapeutic interventions in Europe.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína FUS de Ligação a RNA / Proteínas de Ligação a DNA / Superóxido Dismutase-1 / Proteína C9orf72 / Esclerose Lateral Amiotrófica / Mutação Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Proteína FUS de Ligação a RNA / Proteínas de Ligação a DNA / Superóxido Dismutase-1 / Proteína C9orf72 / Esclerose Lateral Amiotrófica / Mutação Tipo de estudo: Prognostic_studies Limite: Humans País como assunto: Europa Idioma: En Ano de publicação: 2018 Tipo de documento: Article